Local Hospital Held 3rd Annual Spooktacular Stroke Awareness 5K

Translate to Spanish or other 102 languages!

To help bring awareness to this epidemic in America, Rio Grande Regional Hospital hosted its 3rd Annual Spooktacular 5k Run/Walk on October 23rd. Courtesy Image
To help bring awareness to this epidemic in America, Rio Grande Regional Hospital hosted its 3rd Annual Spooktacular 5k Run/Walk on October 23rd. Courtesy Image

Mega Doctor News

- Advertisement -

MCALLEN, Texas – World Stroke Day is observed on October 29 to underscore the serious nature and high rates of stroke.  This day is dedicated to help raise awareness of the prevention and treatment of the condition, to help ensure better care and support for survivors.  Stroke is the number two cause of death in the world and the fifth leading cause of death in the U.S.

To help bring awareness to this epidemic in America, Rio Grande Regional Hospital hosted its 3rd Annual Spooktacular 5k Run/Walk on October 23rd.  Dr. Hamzah Saei, Vascular/Neurologist and Dr. Kevin McMahon, Epileptologist/Neurologist spoke to the crowd and explained the signs and symptoms of a stroke.  In addition, the physicians also encouraged everyone to BE FAST.  BE FAST is an acronym to help detect and enhance responsiveness to the needs of a person having a stroke. The acronym stands for Balance difficulties, Eyesight changes, Facial drooping, Arm weakness, Speech difficulties and Time to call 911. 

PICTURED in RGRH 5K Committee Members:
Front (L-R):  Dr. K. McMahon, Dr. H. Saei
          Middle:  Iza Luna
          Back (L-R):  Adriana Morales, Theresa Escobar, Dulce Olivarez, Claudia Irizarry, David Irizarry, COO
 

Rio Grande Regional Hospital, a Certified Advanced Primary Stroke Center, was recognized by the American Heart Association with the 2021 GWTG Stroke GOLD PLUS with Honor Roll Elite and Target: Type 2 Diabetes Honor Roll. This recognition showcases Rio Grande Regional Hospital’s continuous commitment to provide the residents of the Rio Grande Valley with high quality care while reducing risks and improving lives.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 
- Advertisement -